JP2010280669A5 - - Google Patents

Download PDF

Info

Publication number
JP2010280669A5
JP2010280669A5 JP2010157000A JP2010157000A JP2010280669A5 JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5 JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
independently
case
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010157000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010280669A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010280669A publication Critical patent/JP2010280669A/ja
Publication of JP2010280669A5 publication Critical patent/JP2010280669A5/ja
Withdrawn legal-status Critical Current

Links

JP2010157000A 2002-05-21 2010-07-09 置換複素環式化合物および使用方法 Withdrawn JP2010280669A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38269902P 2002-05-21 2002-05-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004507465A Division JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Publications (2)

Publication Number Publication Date
JP2010280669A JP2010280669A (ja) 2010-12-16
JP2010280669A5 true JP2010280669A5 (cg-RX-API-DMAC7.html) 2011-10-06

Family

ID=29584444

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法
JP2010157000A Withdrawn JP2010280669A (ja) 2002-05-21 2010-07-09 置換複素環式化合物および使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Country Status (10)

Country Link
US (1) US7026326B2 (cg-RX-API-DMAC7.html)
EP (1) EP1506186A1 (cg-RX-API-DMAC7.html)
JP (2) JP4606161B2 (cg-RX-API-DMAC7.html)
AR (1) AR039842A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003234628B2 (cg-RX-API-DMAC7.html)
CA (1) CA2485166A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04011470A (cg-RX-API-DMAC7.html)
PL (1) PL376575A1 (cg-RX-API-DMAC7.html)
TW (1) TW200406399A (cg-RX-API-DMAC7.html)
WO (1) WO2003099808A1 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500128A (ja) * 2003-07-25 2007-01-11 アムジエン・インコーポレーテツド 置換複素環式化合物及び使用方法
CA2535644A1 (en) 2003-08-20 2005-03-03 Amgen Inc. Substituted pyrimdinone derivatives and methods of use
CA2591922A1 (en) * 2004-12-24 2006-06-29 Prosidion Limited G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
US7528448B2 (en) * 2006-07-17 2009-05-05 E.I. Du Pont De Nemours And Company Thin film transistor comprising novel conductor and dielectric compositions
US8062824B2 (en) * 2006-07-17 2011-11-22 E. I. Du Pont De Nemours And Company Thermally imageable dielectric layers, thermal transfer donors and receivers
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
RS51660B (sr) 2007-09-14 2011-10-31 Ortho-Mcneil-Janssen Pharmaceuticals Inc. 1`,3`-disupstituisani-4-fenil-3,4,5,6-tetrahidro-2h, 1`h-[1,4`] bipiridinil-2`-oni
US7666567B2 (en) 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Negative imaging method for providing a patterned metal layer having high conductivity
US7666568B2 (en) * 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Composition and method for providing a patterned metal layer having high conductivity
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
KR20120035158A (ko) 2009-05-12 2012-04-13 얀센 파마슈티칼즈, 인코포레이티드 1,2,4?트리아졸로[4,3?a]피리딘 유도체 및 mGluR2 수용체의 양성 알로스테릭 조절자로서의 그의 용도
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CA2814996C (en) 2010-11-08 2019-10-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JP6085866B2 (ja) 2011-02-28 2017-03-01 アレイ バイオファーマ、インコーポレイテッド セリン/トレオニンキナーゼインヒビター
JP6097289B2 (ja) 2011-08-04 2017-03-15 アレイ バイオファーマ、インコーポレイテッド セリン/スレオニンキナーゼインヒビターとしてのキナゾリン化合物
US9221809B2 (en) 2011-10-31 2015-12-29 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
WO2013082458A1 (en) 2011-12-02 2013-06-06 The Regents Of The University Of California Reperfusion protection solution and uses thereof
DK2820009T3 (en) * 2012-03-01 2018-04-16 Array Biopharma Inc Serine / threonine kinase inhibitors
CA2882750A1 (en) 2012-08-27 2014-03-06 Jim Blake Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
CN109999033B (zh) 2014-01-21 2022-12-23 詹森药业有限公司 包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
HRP20191646T1 (hr) 2014-01-21 2019-12-13 Janssen Pharmaceutica Nv Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba
JP7071965B2 (ja) * 2017-04-11 2022-05-19 三井化学アグロ株式会社 ピリドン化合物およびそれを有効成分とする農園芸用殺菌剤
IL292488B2 (en) * 2017-08-23 2023-09-01 Sprint Bioscience Ab Pyridineamine-pyridone and pyrimidineamine-pyridone compounds
LT3672941T (lt) * 2017-08-23 2022-07-11 Sprint Bioscience Ab Piridilpiridono junginiai
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
US11801238B2 (en) 2020-11-25 2023-10-31 Deciphera Pharmaceuticals, Llc Anti-viral activity of VPS34 inhibitors
AU2023220657A1 (en) * 2022-02-16 2024-08-08 Duke Street Bio Limited Pharmaceutical compound
JP2025541771A (ja) 2022-12-02 2025-12-23 ニューモラ セラピューティクス インコーポレイテッド 神経障害を処置する方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602794A (en) * 1952-07-08 Process for preparation of x-amino-s
WO1995009917A1 (en) 1993-10-07 1995-04-13 The Regents Of The University Of California Genetically engineered bispecific tetravalent antibodies
EP0793504B1 (en) 1994-12-12 2005-06-08 Beth Israel Deaconess Medical Center, Inc. Chimeric cytokines and uses thereof
EA200000825A1 (ru) 1996-02-09 2001-02-26 Амген Инк. Композиция, включающая ингибитор il-1 и полимер, контролирующий высвобождение
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
JP2002514195A (ja) * 1996-12-05 2002-05-14 アムジエン・インコーポレーテツド 置換ピリミジン化合物およびそれの使用
US6410729B1 (en) * 1996-12-05 2002-06-25 Amgen Inc. Substituted pyrimidine compounds and methods of use
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
IL130181A0 (en) * 1996-12-05 2000-06-01 Amgen Inc Substituted pyrimidone and pyridone compounds and methods of use
WO1998024477A1 (en) 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
KR19980066046A (ko) 1997-01-18 1998-10-15 정용훈 고역가의 CTLA4-Ig 융합단백질
CN1202862C (zh) 1997-04-17 2005-05-25 安姆根有限公司 包含具有抗体Fc链的稳定、有活性人OB蛋白的结合物的组合物及方法
CZ20032475A3 (cs) * 2001-03-15 2003-12-17 Basf Aktiengesellschaft 5-Fenylpyrimidiny, způsob jejich přípravy, meziprodukty pro jejich přípravu a jejich použití pro kontrolu škodlivých hub

Similar Documents

Publication Publication Date Title
JP2010280669A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2013102146A5 (ja) 化合物
JP2013521295A5 (cg-RX-API-DMAC7.html)
JP2015042636A5 (ja) 有機化合物
JP2013040159A5 (ja) 有機金属錯体
JP2016503300A5 (cg-RX-API-DMAC7.html)
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2010241801A5 (cg-RX-API-DMAC7.html)
JP2012121883A5 (ja) オキサジアゾール誘導体
JP2015505296A5 (cg-RX-API-DMAC7.html)
JP2011121940A5 (ja) 発光素子
JP2010254680A5 (ja) 複素環化合物、及び発光素子
JP2016540742A5 (cg-RX-API-DMAC7.html)
JP2013542218A5 (cg-RX-API-DMAC7.html)
JP2010095546A5 (cg-RX-API-DMAC7.html)
JP2011528706A5 (cg-RX-API-DMAC7.html)
JP2010523522A5 (cg-RX-API-DMAC7.html)
JP2013100341A5 (cg-RX-API-DMAC7.html)
JP2012109092A5 (cg-RX-API-DMAC7.html)
JP2012149045A5 (ja) ベンゾ[b]ナフト[1,2−d]フラン化合物
JP2012109091A5 (cg-RX-API-DMAC7.html)
JP2014509612A5 (cg-RX-API-DMAC7.html)
JP2014526533A5 (cg-RX-API-DMAC7.html)
JP2013537203A5 (cg-RX-API-DMAC7.html)